Ketoplatin in triple-negative breast cancer cells MDA-MB-231: High efficacy and low toxicity, and positive impact on inflammatory microenvironment
Zhong‐Ying Ma, Xueqing Song, Juanjuan Hu, Dongbo Wang, Xiaojing Ding, Rui-Ping Liu, Miao-Liang Dai, Fanyin Meng, Jing‐Yuan Xu
Topics & Concepts
CisplatinTriple-negative breast cancerIn vivoCancer researchTumor microenvironmentVimentinToxicityChemistryCytotoxicityMesenchymal stem cellBreast cancerEpithelial–mesenchymal transitionMetastasisPharmacologyCancerIn vitroMedicineBiologyImmunologyInternal medicinePathologyChemotherapyBiochemistryTumor cellsBiotechnologyImmunohistochemistryOrganic chemistryCancer Cells and MetastasisCancer-related Molecular PathwaysEstrogen and related hormone effects